2 January 2008

NICE

Balloon catheter dilation of paranasal sinus ostia for chronic sinusitis (interventional procedures consultation) (2nd January 2008)
Sinusitis occurs when air-filled cavities of the face (the sinuses) become inflamed. Balloon catheter dilation aims to keep sinus passages open by gently inflating a small balloon, which is introduced through the nose via a flexible tube. The National Institute for Health and Clinical Excellence is examining balloon catheter dilation of paranasal sinus ostia for chronic sinusitis and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. The Institute's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about balloon catheter dilation of paranasal sinus ostia for chronic sinusitis. Closing date for comments is 30th January 2008.
Click here for the Consultation


Interstitial photodynamic therapy for malignant parotid tumours (interventional procedures consultation) (2nd January 2008)
The parotid glands are located in front of the ears and help to produce saliva. Rarely, they may be affected by malignant tumours. In photodynamic therapy (usually abbreviated to PDT), a drug called a 'photosensitising agent' is injected into a vein. A few days later, special needles and fibres are inserted into the tumour and a special light is shone through them. The light causes the photosensitising agent to destroy the tumour cells. The National Institute for Health and Clinical Excellence is examining interstitial photodynamic therapy for malignant parotid tumours and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. The Institute's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about interstitial photodynamic therapy for malignant parotid tumours. Closing date for comments is 30th January 2008.
Click here for the Consultation


Endoaortic balloon occlusion for cardiac surgery (interventional procedures consultation) (2nd January 2008)
During major heart surgery, the flow of blood through the heart needs to be stopped temporarily. In endoaortic balloon occlusion, a flexible tube (catheter) with a balloon attached to its tip is inserted into an artery in the groin (femoral artery) and threaded up to the heart. When the catheter is in the correct position in the heart, the balloon is filled with saline. As the balloon expands it blocks the aorta, which is the largest artery in the body. With the aorta blocked, the heart surgery can be performed. After heart surgery, the balloon and catheter are removed and the blood flow is restored. The National Institute for Health and Clinical Excellence is examining endoaortic balloon occlusion for cardiac surgery and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. The Institute's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about endoaortic balloon occlusion for cardiac surgery. Closing date for comments is 30th January 2008.
Click here for the Consultation


Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy (interventional procedures consultation) (2nd January 2008)
Intraoperative red blood cell salvage involves the collection of the solid components of the blood lost during an operation, which are then transfused back to the same patient. The National Institute for Health and Clinical Excellence is examining intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. The Institute's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy. Closing date for comments is 30th January 2008.
Click here for the Consultation


Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (interventional procedures consultation) (2nd January 2008)
Type 1 diabetes mellitus occurs when the body does not produce enough insulin (a substance that helps control sugar balance in the body). Although treatable with insulin injections, it is associated with an increased risk of other health problems, such as vascular disease. Allogeneic pancreatic islet cell transplantation involves the removal of islet cells, which are responsible for the production of insulin, from human donors. These cells are inserted into the patient's liver to restart insulin production within the body. Patients who have this procedure take medications so their body's immune system does not reject the cells. It is associated with some serious risks and is only considered in special circumstances. The National Institute for Health and Clinical Excellence is examining allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. The Institute's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. Closing date for comments is 30th January 2008.
Click here for the Consultation


Workplace Physical Activity: consultation on the draft guidance (21st December 2007)
NICE was asked by the Department of Health to develop intervention guidance on workplace health promotion with reference to physical activity. All registered stakeholders for the NICE public health intervention guidance on Workplace Physical Activity are invited to comment on the draft guidance. This consultation will take place between Friday 21st December 2007 and Friday 25th January 2008.
Click here for the Draft Guidance
Click here for the Comments Form


Schizophrenia (update) (21st December 2007)
The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.
Click here for the Final Scope
Click here for the Consultation Table

No comments: